PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies

PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies

PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professio...

Full description

Bibliographic Details
Main Authors:	Bhasker R. Koppula, Gabriel C. Fine, Ahmed Ebada Salem, Matthew F. Covington, Richard H. Wiggins, John M. Hoffman, Kathryn A. Morton
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Cancers
Subjects:	PET FDG esophageal cancer gastric cancer hepatobiliary carcinoma small-bowel carcinoma
Online Access:	https://www.mdpi.com/2072-6694/14/11/2668

Similar Items

PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology
by: Richard H. Wiggins, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
by: Gabriel C. Fine, et al.
Published: (2022-06-01)

PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies
by: Matthew F. Covington, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies
by: Ahmed Ebada Salem, et al.
Published: (2022-11-01)

PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary Malignancies
by: Ahmed Ebada Salem, et al.
Published: (2022-06-01)

Role of 18F FDG PET/CT in evaluation of post-operative ovarian carcinoma
by: Marwa Ibrahim El-Sayed Amer, et al.
Published: (2022-09-01)

18F-FDG PET/CT in a Case of Urothelial Carcinoma in the Urachus Presenting as Colon Cancer
by: Jeannette D. Andersen, et al.
Published: (2021-12-01)

Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
by: Hyunjong Lee, et al.
Published: (2022-06-01)

Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation
by: Yimin Li, et al.
Published: (2019-02-01)

Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
by: Simone Wegen, et al.
Published: (2024-04-01)

An incidental male breast cancer of 18F-FDG PET/CT scanning for esophageal cancer
by: Wenyu Shi, et al.
Published: (2023-04-01)

Role of Pre-therapeutic 18F-FDG PET/CT in Guiding the Treatment Strategy and Predicting Prognosis in Patients with Esophageal Carcinoma
by: Teik Hin Tan, et al.
Published: (2016-07-01)

Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma
by: Guozhu Hou, et al.
Published: (2021-02-01)

FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy
by: Remon Zaher Elia, et al.
Published: (2021-11-01)

The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
by: Sarah M. H. Einerhand, et al.
Published: (2023-05-01)

Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
by: Lianshuang Xia, et al.
Published: (2023-02-01)

Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma
by: David Bonnin, et al.
Published: (2023-04-01)

Tumor Glucose Metabolism and Its Heterogeneity on F-18 FDG PET/CT Provide Better Prognostication in Nonmetastatic Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
by: Hojin Cho, et al.
Published: (2021-11-01)

Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study
by: Masatoshi Hotta, et al.
Published: (2019-01-01)

[<sup>18</sup>F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma
by: Lighea Simona Airò Farulla, et al.
Published: (2023-02-01)

18F‐FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma
by: Shuohua Wang, et al.
Published: (2023-08-01)

Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences
by: Kumar K. Shashi, et al.
Published: (2020-01-01)

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
by: Peter K. Wong, et al.
Published: (2014-05-01)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
by: Hongjia Li, et al.
Published: (2022-10-01)

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
by: Francesco Giammarile, et al.
Published: (2019-11-01)

Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
by: Wei-Hsiang Feng, et al.
Published: (2022-07-01)

Impact of 18F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative 131I whole body scan and elevated serum thyroglobulin
by: Raef Boktor, et al.
Published: (2022-01-01)

State of the Art in 2022 PET/CT in Breast Cancer: A Review
by: Jules Zhang-Yin
Published: (2023-01-01)

PSMA-Positive Low Malignant Gastrointestinal Stromal Tumor in the Stomach on F-18-PSMA-1007 PET/CT
by: Peter Iversen, et al.
Published: (2022-01-01)

Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by 18F-FDG PET/CT: a Case Report and Review of Literature
by: Dominique Fuser, et al.
Published: (2018-01-01)

Survival effect of pretreatment FDG-PET–CT on nasopharyngeal cancer
by: Pei-Chen Yang, et al.
Published: (2023-01-01)

18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
by: Styliani Mantziari, et al.
Published: (2020-01-01)

Multi-Institutional Validation of Two-Streamed Deep Learning Method for Automated Delineation of Esophageal Gross Tumor Volume Using Planning CT and FDG-PET/CT
by: Xianghua Ye, et al.
Published: (2022-01-01)

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol
by: Rahul Jena, et al.
Published: (2023-11-01)

Brown Tumors Due to Primary Hyperparathyroidism in a Patient with Parathyroid Carcinoma Mimicking Skeletal Metastases on 18F-FDG PET/CT
by: Kim Francis Andersen, et al.
Published: (2015-07-01)

Dose escalation guided by 18F-FDG PET/CT for esophageal cancer
by: Bingjie Fan, et al.
Published: (2021-06-01)

Positron Emission Tomography (PET) in Oncology
by: Andrea Gallamini, et al.
Published: (2014-09-01)

Evaluation of relationship between maximum SUV measured on 18F-FDG PET/CT with tumor pathological types, size, lymph node metastasis and distant metastasis in non-small cell lung cancer
by: Sherif Mohsen Ibraheem Yousef Shalaby, et al.
Published: (2022-10-01)

18FDG PET/CT in pulmonary carcinosarcoma and brain metastasis
by: Hamideh Abbasian, et al.
Published: (2019-06-01)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
by: Leila Allahqoli, et al.
Published: (2023-10-01)